Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirus Ghadjar

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 31, 2021
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)Mohamed Shelan, Daniel M Aebersold, Clemens Albrecht, et al.
Urologic Oncology|January 27, 2015
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional seriesGiorgio Gandaglia, Guillaume Ploussard, Hendrik Isbarn, et al.
Radiation Oncology (London, England)|May 13, 2018
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectivesSebastian Zschaeck, Fabian Lohaus, Marcus Beck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2017
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer NetworkPirus Ghadjar, Johannes H Kaanders, Philipp Poortmans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 27, 2013
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10Manfred Sassowsky, Philipp Gut, Tobias Hölscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 5, 2017
Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirementsHana Dobšíček Trefná, Hans Crezee, Manfred Schmidt, et al.
European Urology|January 6, 2026
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 TrialPirus Ghadjar, Stefanie Hayoz, Daniel R Zwahlen, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 31, 2021
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)Mohamed Shelan, Daniel M Aebersold, Clemens Albrecht, et al.
Urologic Oncology|January 27, 2015
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional seriesGiorgio Gandaglia, Guillaume Ploussard, Hendrik Isbarn, et al.
Radiation Oncology (London, England)|May 13, 2018
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectivesSebastian Zschaeck, Fabian Lohaus, Marcus Beck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2017
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer NetworkPirus Ghadjar, Johannes H Kaanders, Philipp Poortmans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 27, 2013
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10Manfred Sassowsky, Philipp Gut, Tobias Hölscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 5, 2017
Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirementsHana Dobšíček Trefná, Hans Crezee, Manfred Schmidt, et al.
European Urology|January 6, 2026
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 TrialPirus Ghadjar, Stefanie Hayoz, Daniel R Zwahlen, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
Pageof 19